Fuso Pharmaceutical Industries,Ltd.
4538
Rank in Stocks
#19061
Fuso Pharmaceutical Industries, Ltd. is a Japanese firm primarily involved in... Fuso Pharmaceutical Industries, Ltd. is a Japanese firm primarily involved in the development and commercialization of pharmaceutical goods. Their product range encompasses prescription medications, particularly injectables and solutions for artificial kidney dialysis, as well as various medical instruments and apparatus. Additionally, the company participates in real estate leasing. Established in 1937, Fuso Pharmaceutical's corporate headquarters are situated in Osaka, Japan.
Share Price
$13.55
Last synced: 2026-11-10
Market Cap
$115.63M
Change (1 day)
0.47%
Change (1 year)
-3.51%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Fuso Pharmaceutical Industries,Ltd. (4538)
Category
Healthcare
Operating Margin for Fuso Pharmaceutical Industries,Ltd. (4538)
Operating Margin as of November 2026 TTM: 4.80%
According to Fuso Pharmaceutical Industries,Ltd.'s latest financial reports, its current operating margin (TTM) is 4.80%. At the end of 2025 the company had an operating margin of 6.82%.
Operating Margin history for Fuso Pharmaceutical Industries,Ltd. from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 4.80% | -29.62% |
| 2025 | 6.82% | 92.11% |
| 2024 | 3.55% | -17.82% |
| 2023 | 4.32% | 11.34% |
| 2022 | 3.88% | -18.66% |
| 2021 | 4.77% | 121.86% |
| 2020 | 2.15% | -21.53% |
| 2019 | 2.74% | 57.47% |
| 2018 | 1.74% | 24.29% |
| 2017 | 1.40% | 115.38% |
| 2016 | 0.65% | -61.54% |
| 2015 | 1.69% | -70.35% |
| 2014 | 5.70% | -27.39% |
| 2013 | 7.85% | 626.85% |
| 2012 | 1.08% | -76.37% |
| 2011 | 4.57% | 361.62% |
| 2010 | 0.99% | 54.69% |
| 2009 | 0.64% | -164.00% |
| 2008 | -1.00% | -171.43% |
| 2007 | 1.40% | -30.69% |
| 2006 | 2.02% | -38.79% |
| 2005 | 3.30% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -95.96% |
DE
|
|
| 19.68% | -95.90% |
DE
|
|
| 13.26% | -97.24% |
JP
|
|
| 17.08% | -96.44% |
CH
|
|
| 14.92% | -96.89% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Fuso Pharmaceutical Industries,Ltd.'s operating margin
What is Fuso Pharmaceutical Industries,Ltd.'s operating margin?
Fuso Pharmaceutical Industries,Ltd.'s operating margin is 4.80%, as of Nov 2026.
What was Fuso Pharmaceutical Industries,Ltd.'s operating margin in 2025?
In 2025, Fuso Pharmaceutical Industries,Ltd.'s operating margin was 6.82%, compared with 3.55% in 2024.
How has Fuso Pharmaceutical Industries,Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Fuso Pharmaceutical Industries,Ltd.'s operating margin was highest in 2025 (6.82%) and lowest in 2020 (2.15%).
How does Fuso Pharmaceutical Industries,Ltd.'s operating margin compare with similar companies?
Fuso Pharmaceutical Industries,Ltd.'s operating margin (4.80%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.